SPOTLIGHT: NZ Activists challenge Herceptin denial

Breast Cancer survivors in New Zealand won a small victory in their challenge to the government's decision not to fund a full course of Herceptin treatment; the women have won the right to see behind-the-scenes documents detailing just how the drug-buying agency made its decision. Report

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.